Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axsome Therapeutics IncfiledCriticalAxsome Therapeutics Inc
Publication of ECSP21006974ApublicationCriticalpatent/ECSP21006974A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
En la presente descripción se describen composiciones que comprenden un fármaco tal como un triptano (por ejemplo, rizatriptán) y/o un AINE (por ejemplo, meloxicam) en combinación con una ciclodextrina y/o un carbonato o un bicarbonato. Estas composiciones pueden administrarse por vía oral, por ejemplo, para mejorar la biodisponibilidad, la solubilidad o la farmacocinética del fármaco para el tratamiento de afecciones tales como el dolor.In the present description compositions comprising a drug such as a triptan (eg rizatriptan) and / or an NSAID (eg meloxicam) in combination with a cyclodextrin and / or a carbonate or bicarbonate are described. These compositions can be administered orally, for example, to improve the bioavailability, solubility or pharmacokinetics of the drug for the treatment of conditions such as pain.
ECSENADI20216974A2019-02-062021-01-29
PHARMACEUTICAL COMPOSITIONS INCLUDING MELOXICAM
ECSP21006974A
(en)
A COMPOSITION THAT INCLUDES 2-N-BUTIL-3- [4- (3-DI-N-BUTILAMINOPROPOXI) BENZOIL] -5-METILSULPHONAMIDE-BENZOFURAN AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS